19
Participants
Start Date
July 1, 2018
Primary Completion Date
July 31, 2020
Study Completion Date
December 31, 2021
Ivabradine
At discharge from the observation unit, subjects will receive a pill bottle containing oral capsules containing active drug to take at home. This arm will require the subject to take the study medication BID for the duration of the study period. Neither study team nor subject will know if the pill bottle contains active drug or placebo.
Placebo
At discharge from the observation unit, subjects will receive a pill bottle containing oral capsules not containing active drug to take at home. This arm will require the subject to take the study medication BID for the duration of the study period. Neither study team nor subject will know if the pill bottle contains active drug or placebo.
Wayne State University, Detroit
Henry Ford Hospital, Detroit
Collaborators (1)
Amgen
INDUSTRY
iRhythm Technologies, Inc.
INDUSTRY
Phillip Levy
OTHER